Frontage Holdings Corporation (“Frontage Holdings” or “Frontage,” stock code: 1521.HK), a Contract Research Organization (“CRO”) providing integrated, science-driven research, analytical and product development services in both the U.S. and China, announced today the opening of a new lab facility in Shanghai, China.
方达医药

视频:方达医药4000平方米上海新实验室正式运营

提供一体化、科学驱动的研究、分析和开发服务,在中美两国同时运营业务的合同研究机构方达控股公司(“方达控股”或“方达”,股份代码:1521.HK),今日宣布其上海新实验室正式投入运营。

zh_CNChinese